These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6134495)

  • 1. Pathogenesis of hyperthyroidism.
    Chopra IJ; Solomon DH
    Annu Rev Med; 1983; 34():267-81. PubMed ID: 6134495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid stimulating immunoglobulin in Graves' disease.
    Luttrell BM; Hales IB
    Aust N Z J Med; 1981 Jun; 11(3):293-8. PubMed ID: 6170289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
    McKenzie JM; Zakarija M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of Graves' disease.
    Gossage AA; Munro DS
    Clin Endocrinol Metab; 1985 May; 14(2):299-330. PubMed ID: 2866051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
    Takasu N; Yamashiro K; Ochi Y; Sato Y; Nagata A; Komiya I; Yoshimura H
    Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb.
    Ochi Y; Kajita Y; Hachiya T; Hamaoki M
    Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assay of circulating thyroid stimulator determined by I- efflux].
    Kobayashi I; Shoda Y; Kuwabara A; Okajima F; Kondo Y
    Rinsho Byori; 1994 Sep; 42(9):938-42. PubMed ID: 7967118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune thyroid disease--a perspective.
    Volpé R
    Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 10. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
    van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
    Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune thyroid disease.
    Bottazzo GF; Doniach D
    Annu Rev Med; 1986; 37():353-9. PubMed ID: 2871804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs.
    Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T
    J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of thyroid antibodies to the postpartum recurrence of hyperthyroidism in Graves' disease.
    Chang TC; Chen FW; Tsai WY; Chen SH; Chang CC; Yu TK; Chen YP; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1987 Feb; 86(2):171-7. PubMed ID: 2883249
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid-stimulating immunoglobulins.
    Pinchera A; Fenzi GF; Macchia E; Bartalena L; Mariotti S; Monzani F
    Horm Res; 1982; 16(5):317-28. PubMed ID: 6129186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
    Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
    Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
    [No Abstract]   [Full Text] [Related]  

  • 19. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
    Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
    Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?
    Brown RS; Jackson IM; Pohl SL; Reichlin S
    Lancet; 1978 Apr; 1(8070):904-6. PubMed ID: 76846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.